As of 2024-12-13, the Intrinsic Value of Rapt Therapeutics Inc (RAPT) is
-16.70 USD. This RAPT valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.03 USD, the upside of Rapt Therapeutics Inc is
-1,721.77%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-16.70 USD
Intrinsic Value
RAPT Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-16.70 - -16.70 |
-16.70 |
-1,721.77% |
| P/E |
(57.13) - (58.46) |
(48.86) |
-4843.7% |
| DDM - Stable |
(18.01) - (54.43) |
(36.22) |
-3616.7% |
| DDM - Multi |
(0.29) - (0.66) |
(0.40) |
-139.2% |
RAPT Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
36.01 |
| Beta |
1.92 |
| Outstanding shares (mil) |
34.96 |
| Enterprise Value (mil) |
-1.89 |
| Market risk premium |
4.60% |
| Cost of Equity |
13.25% |
| Cost of Debt |
5.00% |
| WACC |
8.46% |